Study Title: Improving Cardiovascular Risk in Postmenopausal Women with an (−)-Epicatechin-Based Nutraceutical: A Randomly Assigned, Double-Blind vs. Placebo, Proof-of-Concept Trial
Citation: Garate-Carrillo et al., 2021 · Journal of Medicinal Food
What the Study Found: In postmenopausal women, the (−)-epicatechin-based nutraceutical significantly improved multiple cardiovascular risk markers compared with placebo. It enhanced endothelial function, reduced oxidative stress, and favorably shifted lipid profiles and inflammatory markers. The changes were achieved with good tolerability over the study period.
What this means in real life: After menopause, declining estrogen and mitochondrial efficiency in blood-vessel cells contribute to rising cardiovascular risk. This proof-of-concept trial shows that (−)-epicatechin can help restore vascular health and lower risk factors in this population. Mitochondrial support through targeted flavanols offers a practical way for women to protect heart and metabolic health during this life stage.
Related Content
- Want to understand how mitochondrial health supports healthy blood vessels and blood pressure? → 8 Simple Everyday Habits That Help Keep Your Arteries Healthy
- Curious how cellular energy influences heart and vascular resilience? → 4 Risk Factors for Heart Disease and How to Improve Them Through a Better Understanding of Cellular Energy
- Looking to protect your cardiovascular system at the cellular level? → Mitozz: A New Era in Cellular Energy